Inhibition of invasion and MMPs by a nutrient mixture in human cancer cell lines: A correlation study

Experimental Oncology

Volumn 32, Issue 4, 2010, Pages 243-248

  Roomi, M W ^a   Monterrey, J C ^a   Kalinovsky, T ^a   Rath, M ^a   Niedzwiecki, A ^a  

^a Dr Rath Research Institute   (United States)

Author keywords

Correlation of invasion with MMPs; Human cancer cells; Nutrient mixture

Indexed keywords

ANTIBIOTIC AGENT; ENZYME INHIBITOR; GELATINASE; GELATINASE A; GELATINASE B; MATRIGEL; NUTRIENT MIXTURE; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; TISSUE CULTURE; ZYMOGRAPHY;

CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASMS;

EID: 78650694110     PISSN: 18129269     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Fidler IJ. Molecular biology of cancer: invasion and metastasis. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology, 5th ed. Philadelphia, PA: Lippincott-Raven, 1997; 135-52 pp.
2. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
3. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol 2002; 29: 15-8.
4. Chambers AF, Matrisian LM. Changing views on the role of matrix metalloprotenases in metastasis. J Natl Cancer Inst 1997; 89: 1260-70.
5. Kleiner DL, Stetler-Stevenson WG. Matrix metalloproteinases and metastasis. Cancer Chemother Pharmacol 1999; 43: 42s-51s.
6. Yurchenko PD, Schitny JC. Molecular architecture of basement membranes. FASEB J 1990; 4: 1577-90.
7. Barsky SH, Siegel GP, Jannotta F, et al. Loss of basement membrane components by invasive tumors but not by their benign counterparts. Lab Investig 1983; 49: 140-7.
8. Liotta LA, Tryggvason K, Garbisa A, et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67-8.
9. Stetler-Stevenson WG. The role of matrix metalloproteinases in tumor invasion, metastasis and angiogenesis. Surg Oncol Clin N Am 2001; 10: 383-92.
10. Stetler-Stevenson WG. Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev 1990; 9: 289-303.
11. Nelson AR, Fingleton B, Rothenberg ML, et al. Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000; 18: 1135-49.
12. Bérubé M, Deschambeault A, Boucher M, et al. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment. Mol Vis 2005; 11: 1101-11.
13. Sato T, Sakai T, Noguchi Y, et al. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases. Gynecol Oncol 2004; 92: 47-56.
14. Di Nezza LA, Misajon A, Zhang J, et al. Presence of active gelatinases in endometrial carcinoma and correlation of matrix metalloproteinase expression with increasing tumor grade and invasion. Cancer 2002; 94: 1466-75.
15. Cottam DW, Rennie IG, Woods K, et al. Gelatinolytic metalloproteinase secretion patterns in ocular melanoma. Invest Ophthalmol Vis Sci 1992; 32: 1923-7.
16. Fishman DA, Bafetti L, Banionis S, et al. Production of extracellular matrix degrading proteinases by primary cultures of human epithelial ovarian carcinoma cells. Cancer (Phila) 1997; 80: 1457-63.
17. Garzetti G, Ciavattini A, Lucarini G, et al. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cytstadenocarcinomas: clinical and prognostic implications. Anticancer Res 1995; 15: 2799-804.
18. Gohji K, Fujomoto N, Hara I, et al. Serum matrix metalloproteinase-2 and its density in men with prostate cancer as a new predictor of disease extension. Int J Cancer 1998; 79: 96-101.
19. Roomi MW, Ivanov V, Netke S, et al. In vitro and in vivo antitumor effect of ascorbic acid, lysine, proline, and green tea extract on human melanoma cell line A2058. In vivo 2006; 20: 25-32.
20. Schmalfeldt B, Prechtel D, Härting K, et al. Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001; 7: 2396-404.
21. Maneva-Radicheva L, Ebert U, Dimoudis N, et al. Fibroblast remodeling of adsorbed collagen type IV is altered in contact with cancer cells. Histol Histopathol 2008; 23: 833-42.
22. Ko K, Yazumi S, Yoshikawa K, et al. Activation of fibroblast-derived matrix metalloproteinase-2 by colon cancer cells in no-contact co-cultures. Int J Cancer 2000; 87: 165-71.
23. Sato H, Kida Y, Mai M, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 77-83.